Wikipedia Draft:Exo

Summary
Founded in 2015, Exo (pronounced “Echo”), is a health information and devices company that believes everyone around the world should have access to high-quality, affordable and easy-to-use medical imaging. The company is on a mission to modernize medical imaging through its high-performance ultrasound platform and artificial intelligence. To bring this vision to life, Exo is currently developing a handheld ultrasound device that aims to provide a window into the body, and an intuitive ultrasound workflow solution that works with nearly every point-of-care ultrasound device.

History
Exo’s founders include Chief Executive Officer Sandeep Akkaraju; Executive Board Chairman Janusz Bryzek, Ph.D.; Chief Technology Officer and Executive Vice President of Engineering Yusuf Haque, Ph.D.; and Advisory Board Member John Kokulis.

Sandeep Akkaraju’s vision for Exo began when the technology founder was backpacking through Africa. By that point, Akkaraju had already led a DARPA-funded garage startup into a MEMS technology powerhouse acquired by Corning for $750 million. But what Akkaraju saw in Africa, a world away from the often-insular American technology hubs like Silicon Valley, would make him rethink technology’s impact on the world. To Akkaraju, the contrast could not have been starker—the African villages he visited had little access to the basics of everyday life, things like clean water and simple medical care. They were dealing with potentially treatable medical conditions that often developed into life-altering illnesses.

Akkaraju returned from Africa determined to build a company that would impact the lives of people around the world in indelible ways. It would take him two more successful startups before he could solidify the vision and amass the skills and team to launch Exo, but it was the driving force behind his second act in startup technology. Akkaraju led the reacquisition of IntelliSense, his original startup, from Corning. He <launched and sold Jyve. , a sensor company pioneering the early technology of Augmented Reality, to a large semiconductor firm. All of that experience led to the launch of Exo in 2015, born with the vision to redefine medical imaging and diagnostics for patients worldwide.

Exo has accumulated more than $320M in funding to date and is rapidly proceeding in its mission to take medical imaging everywhere.

Exo’s investors include Action Potential Venture Capital (a GlaxoSmithKline venture fund), AJU, Applied Ventures, LLC, Avidity Partners, BlackRock, Bold Capital Partners, Compal, Creative Ventures, Ferretto Capital, Fiscus Ventures and Reimagined Ventures (Magnetar Capital affiliates), HM Capital, Intel Capital, Longevity Vision Fund, Nautilus Venture Partners, OSF Ventures, Pura Vida Investments, RA Capital Management, Rising Tide, Sands Capital, Sony Innovation Fund by IGV (Innovation Growth Ventures Co., Ltd. (IGV) is managed by Sony Innovation Fund and Daiwa Capital Holdings.), TDK Ventures, Wanxiang Healthcare Investments and Wilson Sonsini

In March 2022, Exo announced the release of their POCUS workflow solution, Exo Works™, to solve for challenges physicians and clinicians experience when documenting and reviewing ultrasound exams.

In June 2022, Exo announced a partnership with Henry Ford Health to help in the testing of their handheld ultrasound product.

In July 2022, Exo acquired Medo, a Canadian-based healthcare technology company that develops Artificial Intelligence (AI) for use in ultrasound.

Products
Exo is building a hardware and software ecosystem for ultrasound that includes releasing a high-performance handheld ultrasound device powered by its patented piezoelectric Micromachined Ultrasound Transducer (pMUT) and a point-of-care ultrasound (POCUS) workflow solution, Exo Works™. The benefits of Exo Works are illustrated on Exo’s product page and in this POCUS 101 article about fixing a broken POCUS workflow. With the release of Exo Works, Exo aims to solve the decades-long infrastructure issue of point-of-care ultrasound, streamlining the ability to review ultrasound exams, document findings, apply billing codes, and archive images—in one platform.

In addition to its ultrasound ecosystem, Exo aims to offer educational components with Exo Works to ease the learning curve for POCUS. Paired with AI capabilities, ultrasound scanning will be made easier and more accessible for clinicians.

Podcast
Exo also has a podcast series, Inside the Exo Chamber, hosted by Andy Berthusen, Vice President of Sales at Exo, and Greg Miller, Vice President of Global Enterprise Sales at Exo.